SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-318186
Filing Date
2020-12-15
Accepted
2020-12-15 17:01:58
Documents
3
Period of Report
2020-12-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d13863d8k.htm 8-K 28777
2 EX-3.1 d13863dex31.htm EX-3.1 28823
3 EX-3.2 d13863dex32.htm EX-3.2 168692
  Complete submission text file 0001193125-20-318186.txt   227582
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 201390229
SIC: 2836 Biological Products, (No Diagnostic Substances)